TILs, mainly composed of CD8+ T cells, CD4+ T cells, Tregs, NK cells, and B cells, orchestrate complex immune responses through the secretion of cytokines that can either promote anti-tumor immunity or support tumor progression [250]. Here, CD8A is linked to neoplasm.